Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ArunA Biomedical names new president and CEO
In addition to his ArunA leadership responsibilities, Mr Sharp has also been appointed to ArunA’s board of directors. Mr Sharp succeeds ArunA founder Steven Stice, who will remain
In addition to his ArunA leadership responsibilities, Mr Sharp has also been appointed to ArunA’s board of directors. Mr Sharp succeeds ArunA founder Steven Stice, who will remain
Barr’s abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic Sensipar product was received as acceptable for filing by the FDA on March 10,
Dormio Tech’s innovative FloChannel is said to be the only diagnostic device that independently monitors left and right nasal airflow. This allows the system to detect and measure
ImaCor’s ClariTEE probe is said to be a miniaturized transesophageal echocardiography probe which facilitates episodic monitoring of cardiac function. The ClariTEE is a single use device that can
The aggregate proceeds to Marshall Edwards from the sale of shares of common stock will be $10 million before expenses. The shares are registered under the Securities Act
The company has applied for orphan drug status in the US and intends doing so for the EU. ReceptoPharm expects to present the clinical findings from the study
The agreement provides for exclusive territory distribution in New York, New Jersey, Maryland, Delaware, Virginia, West Virginia, Ohio, Indiana, Kentucky, Missouri, and Pennsylvania. The territory outside the US
The agreement creates a strategic relationship in which Varian becomes the sole source of radiation therapy systems for MEI Development. Gordon Baltzer, president and CEO of MEI Healthcare
Pediatric Health Care Alliance’s (PHCA) mission is said to provide an advanced delivery system of quality, family-centered healthcare for the pediatric community in the Tampa Bay area. Patrick
Competitive Technologies’s (CTT) pain device is a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs. The EU’s